QQQ   414.09 (-2.20%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
QQQ   414.09 (-2.20%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
QQQ   414.09 (-2.20%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
QQQ   414.09 (-2.20%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
NASDAQ:GRNA

GreenLight Biosciences (GRNA) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.30
$0.30
50-Day Range
$0.30
$0.30
52-Week Range
$0.18
$5.90
Volume
732 shs
Average Volume
486,986 shs
Market Capitalization
$45.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GRNA stock logo

About GreenLight Biosciences Stock (NASDAQ:GRNA)

FUNR manufactures and sells all-natural juice beverages. Its products include pomegranate cranberry, wild berry and passion fruit-orange. The company was founded by Alex C. Procopio on July 22, 1980 and is headquartered in Las Vegas, NV.

GRNA Stock News Headlines

2024's Must-Have Guide: Master Crypto Investment Today
The cryptocurrency revolution is here with Bitcoin soaring past the $70,000 milestone—a clear indicator of the booming digital currency market. Are you prepared to navigate these exciting yet complex waters? Introducing "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024." This free digital guide is your essential resource for understanding and capitalizing on cryptocurrency investments, tailored for both newcomers and seasoned investors. (**By clicking the link you are subscribing to The Conservative Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)
Greenlight Family Cash Card 2023 Review
RNA company to lay off 96 employees in Lexington
2024's Must-Have Guide: Master Crypto Investment Today
The cryptocurrency revolution is here with Bitcoin soaring past the $70,000 milestone—a clear indicator of the booming digital currency market. Are you prepared to navigate these exciting yet complex waters? Introducing "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024." This free digital guide is your essential resource for understanding and capitalizing on cryptocurrency investments, tailored for both newcomers and seasoned investors. (**By clicking the link you are subscribing to The Conservative Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)
Greenlight Screenwriting Lab
See More Headlines
Receive GRNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GreenLight Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GRNA
Fax
N/A
Employees
280
Year Founded
N/A

Profitability

Net Income
$-167,050,000.00
Net Margins
-1,521.00%
Pretax Margin
-1,510.44%

Debt

Sales & Book Value

Annual Sales
$10.20 million
Book Value
$0.32 per share

Miscellaneous

Free Float
105,722,000
Market Cap
$45.43 million
Optionable
Not Optionable
Beta
1.44
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NASDAQ:GRNA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners